title: Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats.
abstract: Several metabolic disturbances during obesity are associated with adipose tissue-altered functions. Adipocytes contain the renin-angiotensin system (RAS), which regulates signalling pathways that control angiogenesis via Akt in an autocrine fashion. Soya protein (Soy) consumption modifies the gene expression pattern in adipose tissue, resulting in an improved adipocyte function. Therefore, the aim of the present work is to study whether dietary Soy regulates the expression of RAS and angiogenesis-related genes and its association with the phosphorylated state of Akt in the adipose tissue of obese rats. Animals were fed a 30 % Soy or casein (Cas) diet containing 5 or 25 % fat for 160 d. mRNA abundance was studied in the adipose tissue, and Akt phosphorylation and hormone release were measured in the primary adipocyte culture. The present results show that Soy treatment in comparison with Cas consumption induces lower angiotensin release and increased insulin-stimulated Akt activation in adipocytes. Furthermore, Soy consumption varies the expression of RAS and angiogenesis-related genes, which maintain cell size and vascularity in the adipose tissue of rats fed a high-fat diet. Thus, adipocyte hypertrophy and impaired angiogenesis, which are frequently observed in dysfunctional adipose tissue, were avoided by consuming dietary Soy. Taken together, these findings suggest that Soy can be used as a dietary strategy to preserve adipocyte functionality and to prevent obesity abnormalities.
authors: Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Seccion XVI, Mexico DF 14000, Mexico.
authors: María E
authors: ME
authors: Frigolet
authors: Nimbe
authors: N
authors: Torres
authors: Armando R
authors: AR
authors: Tovar
mesh_terms: D000809:Angiotensins / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D004041:Dietary Fats / Q000009:adverse effects; D005786:Gene Expression Regulation; D006984:Hypertrophy / Q000517:prevention & control; D007328:Insulin / Q000097:blood / Q000378:metabolism; D050152:Intra-Abdominal Fat / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D009765:Obesity / Q000097:blood / Q000178:diet therapy* / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D014674:Plant Proteins, Dietary / Q000627:therapeutic use*; D011499:Protein Processing, Post-Translational; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012084:Renin-Angiotensin System; D030262:Soybean Proteins / Q000627:therapeutic use*
chemical_list: D000809:Angiotensins; D004041:Dietary Fats; D007328:Insulin; D014674:Plant Proteins, Dietary; D012333:RNA, Messenger; D030262:Soybean Proteins; D051057:Proto-Oncogene Proteins c-akt